迷走神经刺激联合上肢康复治疗卒中的长期结局
VNS-REHAB随机临床试验的事后分析,纳入108例慢性缺血性卒中伴中重度上肢损害患者,接受18次院内强化任务导向康复及3个月家庭锻炼,真实或假刺激;
要点
- 配对迷走神经刺激联合康复在1年时维持上肢损害、活动、参与和生活质量的改善。
- 1年时Fugl-Meyer上肢评分较基线改善5.23(95%CI 4.08-6.39,P<0.001)。
- Wolf运动功能测试较基线改善0.50(95%CI 0.41-0.59,P<0.001)。
核心结论
- 接受配对迷走神经刺激治疗的患者在1年时维持上肢损害、活动、参与和生活质量测量的改善。
研究设计与样本
- VNS-REHAB随机临床试验的事后分析, initially 108 participants across 19 sites with chronic ischemic stroke and moderate-to-severe UE impairment were enrolled。
- 参与者接受18次院内强化任务导向康复和3个月自我发起家庭锻炼,配以真实或假迷走神经刺激;此后对照组交叉接受院内治疗配以主动刺激。
主要发现
- 1年时与基线相比,Fugl-Meyer上肢评分改善5.23(95%CI 4.08-6.39;P<0.001)。
- 1年时与基线相比,Wolf运动功能测试改善0.50(95%CI 0.41-0.59;P<0.001)。
- 1年时与基线相比,Motor Activity Log-Quality of Movement改善0.64(95%CI 0.46-0.82,P<0.001)。
- 1年时与基线相比,Motor Activity Log-Amount of Use改善0.64(95%CI 0.46-0.82,P<0.001)。
- 1年时与基线相比,Stroke Impact Scale-Activities of Daily Living改善7.43(95%CI 5.09-9.77,P<0.001)。
临床怎么用
- 配对迷走神经刺激是FDA批准的有益治疗选择,用于缺血性卒中后慢性上肢受限个体的长期获益。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persistent upper extremity (UE) impairment is common after stroke. Durable treatment benefits for chronic ischemic stroke are needed. The purpose of this report is to determine the long-term effects of vagus nerve stimulation paired with rehabilitation on impairment, activity, and participation in people with UE impairment after ischemic stroke. METHODS: This is a post hoc analysis of data from the VNS-REHAB (A Pivotal Randomized Study Assessing Vagus Nerve Stimulation [VNS] During Rehabilitation for Improved Upper Limb Motor Function After Stroke) randomized clinical trial. Here, we report unblinded, partial crossover, and pooled 1-year outcomes. Initially, 108 participants across 19 sites with chronic ischemic stroke and moderate-to-severe UE impairment were enrolled in VNS-REHAB. Participants received 18 sessions of in-clinic intensive task-specific rehabilitation and 3 months of self-initiated home-based exercise with either real (active) or sham (control) vagus nerve stimulation. Thereafter, Control participants crossed over to receive in-clinic therapy paired with active stimulation. All participants performed home-based exercises paired with self-initiated active stimulation for 1 year. The Fugl-Meyer Assessment UE, Wolf Motor Function Test, and participation outcomes were assessed through 12 months. RESULTS: Seventy-four participants (69%; 51 male; age, mean±SD, 59.6±8.9) completed 1-year follow-up and provided pooled data through 1 year. At 1 year, compared with baseline, there were improvements in impairment (Fugl-Meyer Assessment UE, 5.23 [95% CI, 4.08-6.39]; P<0.001) activity (Wolf Motor Function Test, 0.50 [95% CI, 0.41-0.59]; P<0.001) and patient-reported outcomes (Motor Activity Log-Quality of Movement: 0.64 [95% CI, 0.46-0.82], P<0.001; Motor Activity Log-Amount of Use: 0.64 [95% CI, 0.46-0.82], P<0.001; Stroke Impact Scale-Activities of Daily Living: 7.43 [95% CI, 5.09-9.77], P<0.001; Stroke Impact Scale-Hand: 17.89 [95% CI, 14.16-21.63], P<0.001; EQ-5D: 5.76 [95% CI, 2.08-9.45], P<0.05; and Stroke Specific-Quality of Life: 0.29 [95% CI, 0.19-0.39], P<0.001) compared with baseline. CONCLUSIONS: People treated with paired vagus nerve stimulation maintained improvements in UE impairment, activity, participation, and quality-of-life measures at 1 year. Paired vagus nerve stimulation is a Food and Drug Administration-approved, beneficial treatment option for long-term benefit in individuals with chronic UE limitations after ischemic stroke. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03131960.
引用
- Kimberley TJ, Cramer SC, Wolf SL, et al. Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke. Stroke. 2025. PMID: 40329913. doi:10.1161/STROKEAHA.124.050479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。